Clondiag

Clondiag is a biotechnology company specializing in the development and manufacture of microarray-based diagnostic systems for point-of-care testing. Founded in Jena, Germany, the company gained prominence for its proprietary ArrayTube and ArrayStrip technologies, which enable rapid and multiplexed detection of nucleic acids and proteins. These platforms are primarily utilized for identifying infectious diseases, antibiotic resistance, and environmental pathogens. Following its acquisition by Inverness Medical Innovations (later Alere, now Abbott) in 2006, Clondiag's technology became a cornerstone of the Alere rapid diagnostics portfolio. The company's innovations have significantly advanced the field of decentralized molecular diagnostics.